Skip to main content
Premium Trial:

Request an Annual Quote

Genologics Closes Second Round of VC Cash to Help Market Software

NEW YORK (GenomeWeb News) — Genologics Life Sciences yesterday said it has closed a second round of private equity financing.
 
Genologics said it plans to use the undisclosed funding primarily to market its bioinformatics software to pharmaceutical labs specializing in proteomics, genomics, and systems biology research.
 
The financing was led by OVP Venture Partners and included investments from Growth Works and Yaletown Venture Partners.
 
The company did not disclose the amount of funding it had obtained, but in 2005 the same group of partners, along with Working Opportunity Fund, supplied the company with a total of $5 million in funding.

Filed under

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.